MBP and multiple sclerosis: Our study underscores the role of anti-MBP in secondary morbidity among TSCI patients, highlights its association with multiple sclerosis and Idiopathic polyneuropathy, both characterized by a pathological demyelination [5, 6, 8, 14, 16].